Ayala Pharmaceuticals AYLA
$ 0.5
0.0%
Annual report 2022
added 03-31-2023
Country |
Israel |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Roni Mamluk |
Employees in the company |
31 |
Shares |
15.4 M |
Market Cap[1] |
$ 7.46 M |
EBITDA (LTM) |
$ -37 M |
P/E (LTM) |
-0.2 |
P/S (LTM) |
6.16 |
EPS (LTM) |
-2.54 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.